AI-DRIVEN
Decoding all diseases. Delivering precision.
We are a global specialist in AI- and data-driven precision medicine solutions.
Our platform aims to help pharma, researchers, and clinicians deliver precision care—for every patient, in every disease.
Get in touchBuilt for the People
Who Shape
Healthcare
Our mission is to empower clinicians, researchers, and pharma companies with AI- and data-driven biomedical insights that enable personalized, predictive, and effective care for every patient.
By transforming complex biomedical data into clear, actionable intelligence, we help our partners make smarter decisions—from early discovery to real-world treatment.
Precision medicine isn’t coming. It’s happening—and Mavatar is leading the way.
Technology that redefines
what’s possible in
medicine
Based on 20 years of research and continuous innovation, Mavatar is a global specialist in precision medicine solutions.
At the heart of our technology is DINA—a proprietary framework that analyzes vast biomedical datasets to reveal how diseases work and how patients respond to treatment.
But we’re not stopping there - using DINA, we also create digital twins—virtual models of diseases and patients that simulate treatment responses before anything is prescribed. It’s personalized medicine, powered by AI and real data.
Solutions
Two Solutions. One Mission.
Mavatar supports two distinct areas of healthcare—each built to empower a different kind of decision-maker.
Solution
Pharma Development Support
Our Mavatar Discovery platform is a self-service research platform that helps pharmaceutical companies, biotech firms, and academic researchers accelerate drug development and uncover new therapeutic insights. We also offer tailored services for pharma partners who need custom analysis and reporting.
Learn moreSolution
Personalized Treatment Support
Our Mavatar Precision platform supports doctors in making personalized treatment decisions through digital twin simulations—all with the aim of enabling smarter prescribing and better patient outcomes.Whether you're driving innovation in the lab or delivering care in the clinic, we have the tools to support you.
Learn moreWhy Mavatar?
We're building the foundation for a new era of medicine—one where data drives discovery, and every decision is personalized, predictive, and precise. Rooted in deep science and designed for real-world scale, Mavatar is shaping the future of how we understand, treat, and ultimately prevent disease.
Proven Science, Proprietary Tech
Built on 20+ years of research our DINA framework delivers insights no other platform can—decoding disease biology at a systems level.
Precision at Every Step
From research to treatment, our two platforms —Mavatar Discovery and Mavatar Precision – turn complex data into smarter, faster, personalized decisions.
Digital Twins
Test treatments before they reach real patients. – Our digital twins simulate patient responses, improving trial design, patient selection, and success rates—while cutting costs.
Build for Real-World Impact
Already trusted by global pharma and public partners, Mavatar delivers measurable results: better outcomes, faster development, and less waste.
QUICK FACTS
Mavatar's disease models are computed using extensive publicly available transcriptomic data from multiple sources:
Gene Expression Omnibus (GEO): Over 236,000 datasets with 7.4 million transcriptomes (as of September 2024) CZ
Cell x Gene Discover: 1,501 scRNA-seq datasets with 91.5 million cells (as of September 2024)
Single Cell Portal: 747 scRNA-seq datasets encompassing 50.5 million cells (as of September 2024)
All data undergoes rigorous quality control, annotation, and batch correction before model development.
For each disease model, Mavatar creates approximately 120 Digital Twins that serve as digital representations of both individuals and diseases. These twins capture patient-specific disease alterations by: Generating a diverse population of Digital Twins per disease Matching patient Digital Twins with relevant biomarkers Using meta-analyses of scRNA-seq data to identify distinct patient clusters This approach reflects the heterogeneity among patient groups with similar transcriptomic profiles.
Mavatar's DINA technology analyzes interactions among approximately 22,000 known genes:
Computes gene-gene correlations within a 22,000 × 22,000 data matrix
Maps entire disease mechanisms and pathways Uses network distance as a measure of biological similarity
This comprehensive approach identifies disease-associated pathways within complex genetic networks, forming the foundation of Mavatar's precision medicine platform.
End to End Platforms
Mavatar|Collab
Mavatar Collab is for large to medium-sized pharma companies or research institutions that need more hands-on support with drug development or drug discovery.
.
Mavatar|Precision
Mavatar Precision is created for health-care professionals to act as decision support and helping the patient get the best medication for their specific biology.
.Partner with Mavatar for transformative outcomes
A complete solution, combining cutting-edge AI-driven technology with hands-on collaboration from our team of 25+ PhDs in bioinformatics, genomics, and machine learning. By partnering with Mavatar, you gain a dedicated scientific partner committed to transforming research into real-world medical breakthroughs. Let’s shape the future of medicine together.
Collaborations
LATEST NEWS
Stay Updated with our latest news and insights.
27/04/2025 | NEWS
Mavatar lanserar stängd BETA av Mavatar Discovery – ny plattform för data-driven precisionsmedicin
15/10/2024 | NEWS
